Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease
Brad P. Dieter(Providence Health & Services), Katherine R. Tuttle(Providence Regional Medical Center Everett)
Cited by 18
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
|American Journal of Kidney Diseases|2014|896